Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 4
2004 5
2005 5
2006 5
2007 2
2008 9
2009 5
2010 5
2011 6
2012 5
2013 5
2014 6
2015 6
2016 7
2017 5
2018 3
2019 2
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Nishimura JI, Ando K, Masuko M, Noji H, Ito Y, Mayer J, Griskevicius L, Bucher C, Müllershausen F, Gergely P, Rozenberg I, Schubart A, Chawla R, Rondeau JM, Roguska M, Splawski I, Keating MT, Johnson L, Danekula R, Bagger M, Watanabe Y, Haraldsson B, Kanakura Y. Nishimura JI, et al. Among authors: haraldsson b. Haematologica. 2022 Jun 1;107(6):1483-1488. doi: 10.3324/haematol.2020.265868. Haematologica. 2022. PMID: 35263983 Free PMC article. No abstract available.
The Glomerular Endothelium Restricts Albumin Filtration.
Ballermann BJ, Nyström J, Haraldsson B. Ballermann BJ, et al. Among authors: haraldsson b. Front Med (Lausanne). 2021 Nov 29;8:766689. doi: 10.3389/fmed.2021.766689. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34912827 Free PMC article. Review.
Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
Ebefors K, Wiener RJ, Yu L, Azeloglu EU, Yi Z, Jia F, Zhang W, Baron MH, He JC, Haraldsson B, Daehn I. Ebefors K, et al. Among authors: haraldsson b. Kidney Int. 2019 Oct;96(4):957-970. doi: 10.1016/j.kint.2019.05.007. Epub 2019 May 22. Kidney Int. 2019. PMID: 31402170 Free PMC article.
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Schubart A, Anderson K, Mainolfi N, Sellner H, Ehara T, Adams CM, Mac Sweeney A, Liao SM, Crowley M, Littlewood-Evans A, Sarret S, Wieczorek G, Perrot L, Dubost V, Flandre T, Zhang Y, Smith RJH, Risitano AM, Karki RG, Zhang C, Valeur E, Sirockin F, Gerhartz B, Erbel P, Hughes N, Smith TM, Cumin F, Argikar UA, Haraldsson B, Mogi M, Sedrani R, Wiesmann C, Jaffee B, Maibaum J, Flohr S, Harrison R, Eder J. Schubart A, et al. Among authors: haraldsson b. Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7926-7931. doi: 10.1073/pnas.1820892116. Epub 2019 Mar 29. Proc Natl Acad Sci U S A. 2019. PMID: 30926668 Free PMC article.
Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats.
Najar D, Haraldsson B, Thorsell A, Sihlbom C, Nyström J, Ebefors K. Najar D, et al. Among authors: haraldsson b. Toxins (Basel). 2018 Aug 17;10(8):333. doi: 10.3390/toxins10080333. Toxins (Basel). 2018. PMID: 30126099 Free PMC article.
Patients' Perceptions and Factors Affecting Dialysis Modality Decisions.
Friberg IO, Mårtensson L, Haraldsson B, Krantz G, Määttä S, Järbrink K. Friberg IO, et al. Among authors: haraldsson b. Perit Dial Int. 2018 Sep-Oct;38(5):334-342. doi: 10.3747/pdi.2017.00243. Epub 2018 Jul 31. Perit Dial Int. 2018. PMID: 30065063
84 results